Pregled bibliografske jedinice broj: 947912
Psoriasis Severity—A Risk Factor of Insulin Resistance Independent of Metabolic Syndrome
Psoriasis Severity—A Risk Factor of Insulin Resistance Independent of Metabolic Syndrome // International Journal of Environmental Research and Public Health, 15 (2018), 7; 1486, 7 doi:10.3390/ijerph15071486 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 947912 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Psoriasis Severity—A Risk Factor of Insulin Resistance Independent of Metabolic Syndrome
Autori
Vukšić Polić, Melita ; Miškulin, Maja ; Smolić, Martina ; Kralik, Kristina ; Miškulin, Ivan ; Cigrovski Berković, Maja ; Bilić Čurčić, Ines
Izvornik
International Journal of Environmental Research and Public Health (1660-4601) 15
(2018), 7;
1486, 7
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
psoriasis severity ; insulin resistance ; chronic inflammation ; cardiovascular risk factor
Sažetak
Background: It is still debatable whether psoriasis increases cardiovascular risk indirectly since it is associated with metabolic syndrome or is an independent cardiovascular risk factor. The aim of this study was to evaluate psoriasis severity as an independent predictor of insulin resistance (IR) irrespective of the presence of metabolic syndrome (MetS). Methods: This was a case control study including 128 patients stratified into two groups: patients with psoriasis and metabolic syndrome vs. patients with psoriasis and no metabolic syndrome. MetS was diagnosed according to ATP III criteria with homeostatic model assessment of insulin resistance (HOMA-IR), as well as a homeostatic model assessment of beta cell function (HOMA-β) were calculated. Results: Compared to subjects without metabolic syndrome, patients with metabolic syndrome had a significantly higher Psoriasis Area Severity Index (PASI) values (p < 0.001). The strongest correlation was established for HOMA-IR and the PASI index (p < 0.001), even after adjustment for body mass index (BMI) in regression analysis model. In patients without MetS and severe forms of disease, the HOMA-IR and HOMA-β values were significantly higher compared to mild forms of disease (p < 0.001 for all) while in subjects with MetS no difference was established for HOMA-IR or HOMA-β based on disease severity. Conclusions: Psoriasis severity is an independent risk factor of HOMA-IR, the strongest association being present in the non-MetS group, who still had preserved beta cell function suggesting direct promotion of atherosclerosis via insulin resistance depending on the disease severity, but irrespective of the presence of metabolic syndrome.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti, Javno zdravstvo i zdravstvena zaštita
POVEZANOST RADA
Ustanove:
Klinički bolnički centar Osijek,
KBC "Sestre Milosrdnice",
Medicinski fakultet, Osijek,
Fakultet za dentalnu medicinu i zdravstvo, Osijek
Profili:
Maja Cigrovski Berković
(autor)
Kristina Kralik
(autor)
Ivan Miškulin
(autor)
Martina Smolić
(autor)
Ines Bilić-Ćurčić
(autor)
Maja Miškulin
(autor)
Melita Vukšić Polić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- Social Science Citation Index (SSCI)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE